Is prepregnancy obesity associated with risk of cerebral palsy and epilepsy in children?

Journal of Child Neurology

Volumn 29, Issue 12, 2014, Pages NP196-NP201

  Pan, Chun ^a   Deroche, Chelsea B ^a   Mann, Joshua R ^b   McDermott, Suzanne ^b   Hardin, James W ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Cerebral palsy; Epilepsy; Obesity

Indexed keywords

ARTICLE; BENIGN CHILDHOOD EPILEPSY; BODY MASS; CEREBRAL PALSY; CHILD; CHLAMYDIA; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FEVER; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; MORBID OBESITY; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYPHILIS; WEIGHT GAIN; ADOLESCENT; ADULT; COMPLICATION; EPILEPSY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; YOUNG ADULT;

ADOLESCENT; ADULT; BODY MASS INDEX; CEREBRAL PALSY; COHORT STUDIES; EPILEPSY; FEMALE; HUMANS; MALE; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 84927742211     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813510971     Document Type: Article

References (51)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS data brief, no 82. Hyattsville, MD: National Center for Health Statistics; 2012.
2. Chu SY, Callaghan WM, Bish CL, D'Angelo D. Gestational weight gain by body mass index among US women delivering live births, 2004-2005: fueling future obesity. Am J Obstet Gynecol. 2009;200:271.e1-277.e1.
3. Weisman CS, Hillemeier MM, Downs DS, et al. Preconception predictors of weight gain during pregnancy: prospective findings from the Central Pennsylvania Women's Health Study. Womens Health Issues. 2010;20:126-132.
4. Abrams B, Altman SL, Pickett KE. Pregnancy weight gain: still controversial. Am J Clin Nutr. 2000;71:1233S-1241S.
5. Rasmussen T, Stene LC, Samuelsen SO, et al. Maternal BMI before pregnancy, maternal weight gain during pregnancy, and risk of persistent positivity for multiple diabetes associated autoantibodies in children with the high-risk HLA genotype: the MIDIA study. Diabetes Care. 2009;32:1904-1906.
6. Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med J Aust. 2006;184:56-59.
7. Sholeson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169-2180.
8. Higdon JV, Frei B. Obesity and oxidative stress: a direct link to CVD? Arterioscler Thromb Vasc Biol. 2003;23:365-367.
9. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8 suppl):1527-1534.
10. O'Rourke RW. Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis. World J Surg. 2009;33:2007-2013.
11. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78: 539-552.
12. Boos CJ, Lip GY. Is hypertension an inflammatory process? Curr Pharm Des. 2006;12:1623-1635.
13. Das UN. Hypertension as a low-grade systemic inflammatory condition that has its own origins in the perinatal period. J Assoc Physicians India. 2006;54:133-142.
14. Zulet MA, Puchau B, Navarro C, Martí A, Martínez JA. Inflammatory biomarkers: the link between obesity and associated pathologies. Nutr Hosp. 2007;22:511-527.
15. Odrowaz-Sypniewska G. Markers of pro-inflammatory and prothrombotic state in the diagnosis of metabolic syndrome. Adv Med Sci. 2007;52:246-250.
16. Chudek J, Wiecek A. Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep. 2006;58(suppl):81-88.
17. Oliver E, McGillicuddy F, Phillips, et al. The role of inflammation and macrophage accumulation in the development of obesityinduced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Proc Nutr Soc. 2010;69:232-243.
18. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb. 2010;17:332-341.
19. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2276-2283.
20. Davies GA, Maxwell C, McLeod L, et al; Society of Obstetricians and Gynaecologists of Canada. Obesity in pregnancy. J Obstet Gynaecol Can. 2010;32:165-173.
21. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;33:562-568.
22. Ju H, Chadha Y, Donovan T, O'Rourke P. Fetal macrosomia and pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2009; 49:504-509.
23. Mann JR, McDermott S, Hardin J, et al. Pre-pregnancy body mass index, weight change during pregnancy, and risk of intellectual disability in children. Br J Obstet Gynaecol. 2013;120:309-319.
24. Cui J, de Klerk N, Abramson M, et al. Fractional polynomials and model selection in generalized estimating equations analysis, with an application to a longitudinal epidemiologic study in Australia. Am J Epidemiol. 2009;169:113-121.
25. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
26. StataCorp LP. Stata User's Guide. College Station, TX: Stata Press, StataCorp LP.
27. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modeling (with discussion). Appl Statist. 1994;43:429-467.
28. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964-974.
29. Sauerbrei W, Royston P. Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. J R Stat Soc (Ser A). 1999;162:71-94.
30. Sauerbrei W, Meier-Hirmer C, Benner A, Royston P. Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs. Comput Stat Data Anal. 2006;C50:3464-3485.
31. Dodds L, Fell DB, Shea S, et al. The role of prenatal, obstetric and neonatal factors in the development of autism. J Autism Dev Disord. 2011;41:891-902.
32. Heikura U, Taanila A, Hartikainen AL, et al. Variations in prenatal sociodemographic factors associated with intellectual disability: a study of the 20-year interval between two birth cohorts in northern Finland. Am J Epidemiol. 2008;162:169-177.
33. Neggers YH, Foldenberg RL, Ramey SL, Cliber SP. Maternal prepregnancy body mass index and psychomotor development in children. Acta Obstet Gynecol Scand. 2003;82:235-240.
34. Brion MJ, Zeegers M, Jaddoe V, et al. Intrauterine effects of maternal prepregnancy overweight on child cognition and behavior in 2 cohorts. Pediactrics. 2011;127:e202-e211.
35. Mann JR, Deroche CB, Spiryda LB, McDermott S. Is prepregnancy obesity weight a risk factor for intellectual disability? Expert Rev Obstet Gynecol. 2013;8:197-199.
36. Stanley F, Blair E, Alberman E. Causal pathways initiated preconceptionally or in early pregnancy: Cerebral Palsies: Epidemiology and Causal Pathways. London: MacKeith Press; 2000:48-59.
37. Shatrov JG, Birch SC, Lam T, et al. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol. 2010;116:387-392.
38. Vallejo MC, Burpesh K, Adler LJ, et al. Chorioamnionitis, not epidural analgesia, is associated with maternal fever during labor. Can J Anesth. 2001;48:1122-1126.
39. Curtin WM, Katzman PJ, Flourescue H, Metlay LA. Accuracy of signs of clinical chorioamnionitis in the term parturient. J Perinatol. 2013;33:422-428.
40. Malamitsi-Puchner A, Boutsikou T. Adolescent pregnancy and perinatal outcome. Pediatr Endocrinol Rev. 2006;3(suppl 1): 170-171.
41. Black AY, Fleming NA, Rome ES. Pregnancy in adolescents. Adolesc Med State Art Rev. 2012;23:123-138.
42. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol. 2006;49:257-269.
43. Stoinska B, Gadzinowski J. Neurological and developmental disabilities in ELBW and VLBW: follow-up at 2 years of age. J Perinatol. 2011;31:137-142.
44. Aylward GP. Neurodevelopmental outcomes of infants born prematurely. J Dev Behav Pediatr. 2005;26:427-440.
45. McIntyre S, Taitz D, Keogh J, et al. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol. 2013;55:499-508.
46. Pandolfo M. Genetics of epilepsy. Semin Neurol. 2011;31: 506-518.
47. Palac L, Ribble JC, Keddie AM. Antiepileptic drugs and neurodevelopment: an update. Curr Neurol Neurosci Rep. 2011;11(4): 423-427.
48. MMWR. Epilepsy surveillance among adults-19 states, Behavioral Risk Factor Surveillance System. CDC. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5706a1.htm.
49. Chong J, Hesdorffer DC, Thurman DJ, et al. The prevalence of epilepsy along the Arizona-Mexico border. Epilepsy Rev. 2013; 105:206-215.
50. Kelvin EA, Hesdorffer DC, Bagiella E, et al. Prevalence of selfreported epilepsy in a multiracial and multiethnic community in New York City. Epilepsy Rev. 2007;77:141-150.
51. Franzini L, Ribble JC, Keddie AM. Understanding the Hispanic paradox. Ethn Dis. 2001;11:496-518.